Kaposi's sarcoma-associated herpesvirus K7 induces viral G protein-coupled receptor degradation and reduces its tumorigenicity.
Kaposi's sarcoma-associated herpesvirus K7 induces viral G protein-coupled receptor degradation and reduces its tumorigenicity.
复制标题
DOI:
10.1371/journal.ppat.1000157
复制
发表时间:
2008-09-19
期刊:
影响因子:
6.7
通讯作者:
Feng P
中科院分区:
文献类型:
--
作者:
Feng H;Dong X;Negaard A;Feng P
The Kaposi's sarcoma-associated herpesvirus (KSHV) genome encodes a G protein-coupled receptor (vGPCR). vGPCR is a ligand-independent, constitutively active signaling molecule that promotes cell growth and proliferation; however, it is not clear how vGPCR is negatively regulated. We report here that the KSHV K7 small membrane protein interacts with vGPCR and induces its degradation, thereby dampening vGPCR signaling. K7 interaction with vGPCR is readily detected in transiently transfected human cells. Mutational analyses reveal that the K7 transmembrane domain is necessary and sufficient for this interaction. Biochemical and confocal microscopy studies indicate that K7 retains vGPCR in the endoplasmic reticulum (ER) and induces vGPCR proteasomeal degradation. Indeed, the knockdown of K7 by shRNA-mediated silencing increases vGPCR protein expression in BCBL-1 cells that are induced for KSHV lytic replication. Interestingly, K7 expression significantly reduces vGPCR tumorigenicity in nude mice. These findings define a viral factor that negatively regulates vGPCR protein expression and reveal a post-translational event that modulates GPCR-dependent transformation and tumorigenicity. Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiological agent of Kaposi's sarcoma. KSHV is also found in primary effusion lymphoma and multicentric Castleman's disease, rare lymphoproliferative diorders associated with immuno-suppression. The KSHV genome encodes a G protein-coupled receptor (vGPCR) that is believed to contribute to the KSHV-associated malignancies. vGPCR is a ligand-independent, constitutively active signaling molecule. It is not clear how vGPCR is negatively regulated. Here, we report that the KSHV small membrane K7 protein interacts with vGPCR through its putative transmembrane domain. Interaction with K7 retains vGPCR in the ER and facilitates its degradation by the proteasome, thereby reducing vGPCR protein expression. Consequently, K7 significantly reduces vGPCR-mediated transformation in vitro and tumor formation in nude mice. Our findings reveal that K7 functions as a viral factor to dampen vGPCR protein expression and negatively modulate the tumor-inducing capacity of vGPCR, implying that KSHV has evolved mechanisms to avoid deleterious effects and to permit persistent infection within its host.
登录
查看更多内容
影响因子:
5.4
作者:
Feng, PH;Park, J;Jung, JU
通讯作者:
Jung, JU
DOI:
10.1084/jem.187.5.801
发表时间:
1998-03-02
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Geras-Raaka E;Arvanitakis L;Bais C;Cesarman E;Mesri EA;Gershengorn MC
通讯作者:
Gershengorn MC
影响因子:
64.8
作者:
Lilley, BN;Ploegh, HL
通讯作者:
Ploegh, HL
DOI:
10.1006/bbrc.1998.9557
发表时间:
1998-12-30
影响因子:
3.1
作者:
Geras-Raaka, E;Varma, A;Gershengorn, MC
通讯作者:
Gershengorn, MC
影响因子:
82.9
作者:
Lee, H;Veazey, R;Jung, JU
通讯作者:
Jung, JU